Literature DB >> 19643804

Anti-Mullerian hormone and inhibin B levels as markers of premature ovarian aging and transition to menopause in type 1 diabetes mellitus.

Néstor Soto1, Germán Iñiguez, Patricia López, Gladys Larenas, Verónica Mujica, Rodolfo A Rey, Ethel Codner.   

Abstract

BACKGROUND: Serum anti-Müllerian hormone (AMH) levels decrease early during the transition to menopause and women with type 1 diabetes mellitus (DM1) experience menopause at a younger age. We hypothesized that older women with DM1 will have lower AMH levels than controls.
METHODS: We studied ovarian function in women with DM1 (n = 66) and healthy controls (n = 58), all <45 years old. Steroids, gonadotrophins, AMH and inhibin B levels were measured during the follicular phase.
RESULTS: Piece-wise regression analysis demonstrated that AMH levels begin to decrease at 33 years of age in both groups. This age limit was used to compare data in both groups. AMH levels were lower in DM1 women than in controls >33 years (4.1 +/- 4.2 versus 9.5 +/- 7.9 pmol/l, mean +/- SD, P = 0.006). A higher proportion of women with DM1 showed AMH levels in the menopausal range compared with controls (16.7% versus 3.4%, respectively, P = 0.02). For all patients, those with DM1 exhibited lower inhibin B levels than controls (89.3 +/- 51.7 versus 113.2 +/- 76.0 ng/ml, P < 0.05). FSH and estradiol were similar in both groups. Regression analysis showed an earlier decline in AMH levels in women with DM1 than controls. Even after age adjustment, DM1 was a significant factor for the determination of inhibin B and AMH levels.
CONCLUSIONS: Lower AMH levels in women with DM1 during the fourth decade of life suggest the presence of an earlier decline in the ovarian follicle pool in these women. Further studies are needed to evaluate the mechanism of this complication.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19643804     DOI: 10.1093/humrep/dep276

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  18 in total

1.  Ovarian markers and irregular menses among women with type 1 diabetes in the Epidemiology of Diabetes Interventions and Complications study.

Authors:  C Kim; R S Miller; B H Braffett; Y Pan; V L Arends; A K Saenger; A Barnie; A V Sarma
Journal:  Clin Endocrinol (Oxf)       Date:  2018-01-26       Impact factor: 3.478

Review 2.  Ovarian aging in women with diabetes: An overview.

Authors:  Melissa F Wellons; Juliana J Matthews; Catherine Kim
Journal:  Maturitas       Date:  2016-12-02       Impact factor: 4.342

3.  Oestradiol levels may differ between premenopausal women, ages 18-50, with type 1 diabetes and matched controls.

Authors:  Lina Saleh Hassan; Rebecca S Monson; Kirstie K Danielson
Journal:  Diabetes Metab Res Rev       Date:  2016-06-30       Impact factor: 4.876

4.  The diabetes-fracture association in women with type 1 and type 2 diabetes is partially mediated by falls: a 15-year longitudinal study.

Authors:  E P Thong; F Milat; J C Enticott; A E Joham; P R Ebeling; G D Mishra; H J Teede
Journal:  Osteoporos Int       Date:  2021-01-07       Impact factor: 4.507

5.  Antimüllerian hormone among women with and without type 1 diabetes: the Epidemiology of Diabetes Interventions and Complications Study and the Michigan Bone Health and Metabolism Study.

Authors:  Catherine Kim; Carrie Karvonen-Gutierrez; Shengchun Kong; Valerie Arends; Michael Steffes; Daniel S McConnell; John F Randolph; Siobán D Harlow
Journal:  Fertil Steril       Date:  2016-07-28       Impact factor: 7.329

6.  Assessment of ovarian reserve in patients with type 1 diabetes: a systematic review and meta-analysis.

Authors:  Xiaoling Cai; Linong Ji; Wenjia Yang; Chu Lin; Mengqian Zhang; Fang Lv; Xingyun Zhu; Xueyao Han
Journal:  Endocrine       Date:  2022-05-30       Impact factor: 3.925

7.  Ovarian reserve in women with Type 1 diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.

Authors:  C Kim; R L Dunn; B Braffett; P A Cleary; V Arends; M Steffes; M S M Lanham; J F Randolph; H Wessells; M F Wellons; A V Sarma
Journal:  Diabet Med       Date:  2016-05       Impact factor: 4.359

8.  Diabetes and onset of natural menopause: results from the European Prospective Investigation into Cancer and Nutrition.

Authors:  J S Brand; N C Onland-Moret; M J C Eijkemans; A Tjønneland; N Roswall; K Overvad; G Fagherazzi; F Clavel-Chapelon; L Dossus; A Lukanova; V Grote; M M Bergmann; H Boeing; A Trichopoulou; M Tzivoglou; D Trichopoulos; S Grioni; A Mattiello; G Masala; R Tumino; P Vineis; H B Bueno-de-Mesquita; E Weiderpass; M L Redondo; M J Sánchez; J M Huerta Castaño; L Arriola; E Ardanaz; E J Duell; O Rolandsson; P W Franks; S Butt; P Nilsson; K T Khaw; N Wareham; R Travis; I Romieu; M J Gunter; E Riboli; Y T van der Schouw
Journal:  Hum Reprod       Date:  2015-03-15       Impact factor: 6.918

Review 9.  The ageing ovary and uterus: new biological insights.

Authors:  S M Nelson; E E Telfer; R A Anderson
Journal:  Hum Reprod Update       Date:  2012-10-26       Impact factor: 15.610

10.  A validated model of serum anti-müllerian hormone from conception to menopause.

Authors:  Thomas W Kelsey; Phoebe Wright; Scott M Nelson; Richard A Anderson; W Hamish B Wallace
Journal:  PLoS One       Date:  2011-07-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.